2cureX AB (2QE) Stock Statistics & Valuation Metrics

2cureX AB has a market cap or net worth of €1.74M. The enterprise value is ―.

2cureX AB has 25,102,917 shares outstanding. The number of shares has decreased by -2.65% in one year.

2cureX AB’s return on equity (ROE) is -0.81 and return on invested capital (ROIC) is -93.04%.

The current PE Ratio of 2cureX AB is ―. 2cureX AB’s PEG ratio is 0.02.

In the last 12 months, 2cureX AB had revenue of 0.00 and earned -4.13M in profits. Earnings per share was -0.20.

In the last 12 months, operating cash flow was -22.59M and capital expenditures -17.00K, giving a free cash flow of -22.61M billion.

2cureX AB pays an annual dividend of ―, resulting in a dividend yield of ―

2cureX AB upcoming earnings date is Feb 26, 2026, TBA (Confirmed).

2cureX AB as a current ratio of 2.93, with Debt / Equity ratio of 0.00%

In the past 12 months, 2cureX AB has paid 0.00 in taxes.

2cureX AB EV to EBITDA ratio is -0.91, with an EV/FCF ratio of -0.81.

2cureX AB has €3.13M in cash and marketable securities with €0.00 in debt, giving a net cash position of €3.13M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for 2cureX AB is ―, which is 11.43% higher than the current price. The consensus rating is ―